Teladoc Health, Inc.
NYSETeladoc Health heads into its October 30 quarterly results carrying 15.8% of its free float in short positions, a stock trading below $6, and a CEO who sold shares just weeks after a 30% post-earnings collapse. Short interest is the central tension here. At 15.8% of free float, the position is elevated and has climbed sharply over the past month, up roughly 19% in absolute share…
TDOC cost to borrow surges 216% in one week to 0.41%, highest jump since June as shorts rebuild post-earnings despite loose availability at 394%.
Snapshot as of 7 Oct 2026
Teladoc Health heads into its October 30 quarterly results carrying 15.8% of its free float in short positions, a stock trading below $6, and a CEO who sold shares just weeks after a 30% post-earnings collapse. Short…
Teladoc Health has crossed its July 28 earnings event with the pre-print bullish setup now unwinding — shorts are rebuilding and the call-heavy options skew that defined last week has largely normalised. The clearest…
Teladoc Health heads into its July 28 earnings report with options traders unusually bullish and short sellers quietly trimming positions — a rare alignment of bullish signals for a stock that has spent much of 2026…
Teladoc Health heads into its July 28 earnings date with a striking disconnect: the stock has rallied 35% in a month, yet short sellers are adding, not leaving. The most interesting development this week came from the…
Teladoc Health enters its May 21 earnings date with a notable shift under the hood: short sellers have been covering meaningfully over the past month, even as the stock trades near multi-year lows at $5.95. The short…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TDOC — free to start on ORTEX.
Sign up for free →Open TDOC on ORTEX